C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, Barclays lowered the firm’s price target on C4 Therapeutics to $5 from $10, ...

KUWAIT - Kuwait will sign a contract next week with China Communications Construction ‍Company (CCCC) to complete ‍the Mubarak Al-Kabeer Port project, Public Works Minister Noura Al-Mashaan said on ...

To get a sense of who is truly in control of C4 Therapeutics, Inc. (NASDAQ:CCCC), it is important to understand the ownership structure of the business. We can see that institutions own the lion's ...

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid ...

The Kuwaiti Ministry of Public Works and China Communications Construction Company Limited (CCCC) on Friday signed an engineering, procurement and construction (EPC) contract for the first phase of ...

A U.S. Navy sailor is charged with murder after he allegedly killed his two roommates, who were also sailors.

KUWAIT CITY, Dec. 22 (Xinhua) -- The Kuwaiti Ministry of Public Works and China Communications Construction Company Limited (CCCC) on Friday signed an engineering, procurement and construction (EPC) ...

Kuwait will sign a contract next week with China Communications Construction Company (CCCC) to complete the Mubarak Al-Kabeer Port project, Public Works Minister Noura Al-Mashaan said on Thursday. The ...